Immune checkpoint inhibitors in

Humans Immune Checkpoint Inhibitors / pharmacology Proto-Oncogene Proteins B-raf / genetics Nivolumab / therapeutic use Colorectal Neoplasms / drug therapy Prognosis
BRAF-mutated colorectal cancer advanced cancer clinical trials immune checkpoint inhibitors immunotherapy treatment regimen

Journal

Future oncology (London, England)
ISSN: 1744-8301
Titre abrégé: Future Oncol
Pays: England
ID NLM: 101256629

Informations de publication

Date de publication:
Nov 2023
Historique:
medline: 1 12 2023
pubmed: 22 11 2023
entrez: 22 11 2023
Statut: ppublish

Résumé

Colorectal cancer has been around for a long time, but is still a challenge nonetheless. However, the heterogeneity of the disease opens new potential therapeutic doors.

Identifiants

DOI: 10.2217/fon-2022-0978 PMID: 37990891
pubmed: 37990891
doi: 10.2217/fon-2022-0978
doi:

Substances chimiques

Immune Checkpoint Inhibitors 0
Proto-Oncogene Proteins B-raf EC 2.7.11.1
Nivolumab 31YO63LBSN
BRAF protein, human EC 2.7.11.1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2417-2424

Auteurs

Rebecca Kassab (R)

Department of Hematology & Oncology, Saint Joseph University, Beirut, Lebanon.
ORCID: 0000-0002-2429-6526

Michel Abou Khalil (MA)

Department of Hematology & Oncology, Saint Joseph University, Beirut, Lebanon.

Joseph Kassab (J)

Department of Hematology & Oncology, Saint Joseph University, Beirut, Lebanon.
ORCID: 0000-0001-6761-7636

Hampig Raphael Kourie (HR)

Department of Hematology & Oncology, Saint Joseph University, Beirut, Lebanon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Immune checkpoint inhibitors in
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antinéoplasiques › Antinéoplasiques immunologiques › Inhibiteurs de points de contrôle immunitaires › Immune checkpoint inhibitors in
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines oncogènes › Protéines proto-oncogènes › Kinases raf › Protéines proto-oncogènes B-raf › Immune checkpoint inhibitors in
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps monoclonaux › Anticorps monoclonaux humanisés › Nivolumab › Immune checkpoint inhibitors in
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Maladies intestinales › Maladies du rectum › Tumeurs colorectales › Immune checkpoint inhibitors in
questionsmedicales.fr › Diagnostic › Pronostic › Immune checkpoint inhibitors in